Brainstorm Cell Therapeutics (BCLI) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Brainstorm Cell Therapeutics (NASDAQ: BCLI): 7/29/2024 – Brainstorm Cell Therapeutics is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 7/21/2024 – Brainstorm Cell Therapeutics is now covered by analysts at StockNews.com. They set a “hold” rating on the […]
More Stories
LMR Partners LLP Grows Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
LMR Partners LLP raised its position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 96.2% during the...
OneAscent Wealth Management LLC Invests $203,000 in Johnson & Johnson (NYSE:JNJ)
OneAscent Wealth Management LLC bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the third quarter,...
OneAscent Wealth Management LLC Makes New $330,000 Investment in Houlihan Lokey, Inc. (NYSE:HLI)
OneAscent Wealth Management LLC purchased a new stake in shares of Houlihan Lokey, Inc. (NYSE:HLI – Free Report) during the...
Pathstone Holdings LLC Cuts Position in Dimensional US Large Cap Value ETF (NYSEARCA:DFLV)
Pathstone Holdings LLC reduced its holdings in shares of Dimensional US Large Cap Value ETF (NYSEARCA:DFLV – Free Report) by...
Pathstone Holdings LLC Reduces Holdings in The TJX Companies, Inc. (NYSE:TJX)
Pathstone Holdings LLC reduced its stake in shares of The TJX Companies, Inc. (NYSE:TJX – Free Report) by 9.0% during...
Savoir Faire Capital Management L.P. Buys 12,780 Shares of US Foods Holding Corp. (NYSE:USFD)
Savoir Faire Capital Management L.P. grew its holdings in shares of US Foods Holding Corp. (NYSE:USFD – Free Report) by...